迪安診斷(300244.SZ):2015年度員工持股計劃存續期延長
格隆匯11月29日丨迪安診斷(300244.SZ)公佈,鑑於公司2015年度員工持股計劃將於2020年2月4日到期,根據中國證監會《關於上市公司實施員工持股計劃試點的指導意見》、《2015年度員工持股計劃(草案)》的相關要求,將公司2015年度員工持股計劃存續期延長至2021年2月4日。
截至公告披露日,2015年度員工持股計劃剩餘股票數量366.8萬股,剩餘股票數量佔公司總股本的0.59%。公司2015年度員工持股計劃持有的公司股票均未出現用於抵押、質押、擔保、償還債務等情形;未出現任一持有人持有的2015年度員工持股計劃份額所對應的公司股票數量超過公司股本總額1%的情形;未出現2015年度員工持股計劃持有人之外的第三人對員工持股計劃的股票和資金提出權利主張的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.